New York, June 1 (IANS) Indian-origin researcher Dr Abhishek Jain, from the Department of Biomedical Engineering at Texas A&M University in the US, and his team are developing a vessel-chip technology for more personalised pharmaceutical drug testing.
Jain’s lab, which also has Dr Tanmay Mathur in the team, received a grant from Texas A&M Innovation to continue developing an advanced vessel-chip deployment platform for large-scale pharmaceutical testing.
According to him, this system can be used from discovery all the way to the translational pipeline, where you can immediately initiate informed clinical trials of venous, vascular and hematological diseases and know what the outcome on an actual human might be.
“You can fine-tune your clinical trials or reduce the length of the clinical trials and make them much more efficient,” he said in a university statement.
Jain and his lab have focused their research efforts on creating blood and lymphatic vessel-chips.
These are tissue-engineered microfluidic devices that mimic human circulatory systems and provide a platform for preclinical drug discovery.
His work has culminated in the founding of a startup company with his current and past trainees.
The Texas A&M Innovation Translational Investment Fund (TIF) grant will help build confidence in customers by ensuring that the vessel-chips are reliable, reproducible and automated for ease of use, according to researchers.
Jain said the momentum offered by the TIF also allowed him to hire Dr. Tanmay Mathur, a previous graduate student of Jain’s, to help make the startup successful.
–IANS
na/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
